In-Process Research and Development, Net (Details) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| In-Process Research and Development, Net [Line Items] | ||||
| Research and development, net balance | $ 1,053,869 | $ 1,621,325 | $ 4,287,106 | $ 7,514,888 |
| LYMPHIR [Member] | ||||
| In-Process Research and Development, Net [Line Items] | ||||
| Research and development,carrying value | 73,400,000 | |||
| Research and development, net balance | 69,385,938 | |||
| Amortization | $ 1,720,312 | 4,014,062 | ||
| LMB and Mino-Lok [Member] | ||||
| In-Process Research and Development, Net [Line Items] | ||||
| Amortization of in-process research and development excludes acquisition | $ 19,400,000 | |||
| X | ||||||||||
- Definition The amount of amortization of in process research and development excludes acquisition. No definition available.
|
| X | ||||||||||
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|